Timing of Initiation of Renal-Replacement Therapy of Acute Kidney Injury (STARRT-AKI)
Sean Bagshaw, Ron Wald
The STARRT-AKI trial is an international, multi-center, open-label, randomized controlled trial that compared an accelerated strategy to the initiation of RRT versus a conservative strategy to the initiation of RRT, as guided by standard indications and clinical judgement in critically ill patients with AKI, on 90-day all-cause mortality (primary), RRT dependence (secondary) and a spectrum of additional outcomes.
Key publications:
STARRT-AKI statistical analysis plan
Secondary publications:
STARRT-AKI (Bayesian Re-analysis)
STARRT-AKI (RRT Baseline Risk)
Program publications:
CANAKI II study (observational)
CANAKI I study (observational)
CANAKI study (survey of practice)
For more Information, visit the STARRT-AKI trial website